Press Release

January 08, 2024 | Press Release
Pleno Deploys its RAPTOR Instrument Platform Available with TotalSeq™ Antibodies from BioLegend
November 02, 2023 | Press Release
ProJenX Announces Initial Closing of $15M Series A Financing and Appoints Rick Hartz to Board of Directors
November 01, 2023 | Press Release
Immunitas Therapeutics Presents Data for Novel Anti CLEC2D-TLR9 Conjugate Program at the Society for Immunotherapy of Cancer 2023 Annual Meeting
October 30, 2023 | Press Release
AVILAR THERAPEUTICS TO PRESENT NEW DATA FOR ATAC EXTRACELLULAR PROTEIN DEGRADERS AT TARGETED PROTEIN DEGRADATION SUMMIT
October 19, 2023 | Press Release
FDA Grants Fast Track Designation to ANPD001, Autologous Investigational Cell Therapy for the Treatment of Parkinson’s Disease
September 21, 2023 | Press Release
Nobias Therapeutics Announces Acceptance of Late-Breaking Abstract and Presentation of Phase 2 Clinical Data for NB-001 at 52nd Child Neurology Society Annual Meeting
September 19, 2023 | Press Release
AVILAR THERAPEUTICS TO PRESENT AT UPCOMING INDUSTRY CONFERENCES
August 24, 2023 | Press Release
Aspen Neuroscience to Partner with Rune Labs and Emerald Innovations to Incorporate both Active and Passive Digital Health Monitoring in Trial Ready Cohort Screening Study
August 08, 2023 | Press Release
Aspen Neuroscience Announces FDA Clearance of Investigational New Drug Application for ANPD001, Autologous Cell Therapy for the Treatment of Parkinson’s Disease
July 25, 2023 | Press Release
Truvian Health Presents Multi-Site Clinical Study Data on Its Benchtop Blood Testing Platform to Enable Central Laboratory Quality Results Anywhere